• N/A
    Market Cap
  • -87.54%
    1-Year Change
  • Drug Manufacturers - Specialty & Generic
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
Income Statement
Total Operating Revenue
116.4M
-37.56%
186.4M
N/A
Cost of Revenue
92.5M
-2.70%
95.1M
N/A
Gross Profit
23.9M
-73.86%
91.3M
N/A
Sales and Marketing Expense
43.9M
+6.42%
41.3M
N/A
Research and Development Expense
-18.0M
+40.79%
-12.8M
N/A
Depreciation and Amortization Expense
25.9M
+7.12%
24.2M
N/A
Total Operating Expenses
94.4M
+26.08%
74.9M
N/A
Operating Profit
-70.5M
-528.89%
16.4M
N/A
Interest Income
96,000
-58.44%
231,000
N/A
Interest Expense
-3.4M
-15.90%
-4.0M
N/A
Interest Income and Expense and Net
-3.3M
-13.33%
-3.8M
N/A
Total Nonoperating Income and Expense
-1.4M
-33.15%
-2.0M
N/A
Income before Taxes
-71.9M
-599.33%
14.4M
N/A
Income Taxes
11.1M
+1,100.76%
924,000
N/A
Extraordinary Items
12.8M
+114.71%
6.0M
N/A
Net Income
-69.8M
-716.96%
11.3M
N/A
Net Income from Continuing Operations Applicable to Common
-71.9M
-599.33%
14.4M
N/A
Basic EPS and Net Income
-1.47
-688.00%
0.25
N/A
Diluted EPS and Net Income
-1.47
-688.00%
0.25
N/A
Basic Weighted Average Shares
47.3M
+3.69%
45.7M
N/A
Diluted Weighted Average Shares
47.3M
+3.69%
45.7M
N/A
Balance Sheet
Cash and Cash Equivalents
50.3M
+170.54%
18.6M
N/A
Short-Term Investments
1.6M
+8.86%
1.4M
N/A
Cash and Cash Equivalents and Short-Term Investments
51.9M
+158.98%
20.0M
N/A
Total Current Assets
137.4M
-22.61%
177.6M
N/A
Accumulated Depreciation
131.8M
+18.13%
111.6M
N/A
Property and Plant and Equipment and Net
236.8M
-7.19%
255.2M
N/A
Total Long-Term Assets
299.1M
-5.27%
315.7M
N/A
Total Assets
436.5M
-11.51%
493.2M
N/A
Income Taxes Payable
2.4M
+18.54%
2.1M
N/A
Total Short-Term Debt
65.8M
-19.40%
81.6M
N/A
Total Current Liabilities
120.5M
-11.35%
135.9M
N/A
Total Long-Term Debt
8.8M
+84.38%
4.8M
N/A
Total Long-Term Liabilities
9.3M
+93.35%
4.8M
N/A
Total Liabilities
129.8M
-7.78%
140.7M
N/A
Retained Earnings
-21.6M
-144.93%
48.2M
N/A
Total Stockholders Equity
249.8M
-12.01%
284.0M
N/A
Total Shares Outstanding
7.4M
-83.81%
45.7M
N/A
Cash Flow
Cash from Operating Activities
13.3M
-67.52%
41.0M
N/A
Capital Expenditures
1.0M
-92.58%
13.6M
N/A
Cash from Investing Activities
-12.6M
-54.35%
-27.7M
N/A
Dividends Paid
N/A
N/A
16.0M
N/A
Cash from Financing Activities
32.3M
+246.01%
-22.1M
N/A
Financials Ratio
Gross Margin
20.51%
N/A
N/A
N/A
Operating Margin
-60.59%
N/A
N/A
N/A
Return on Assets
-15.01%
N/A
N/A
N/A
Return on Equity
-26.15%
N/A
N/A
N/A
Revenue Growth
-37.56%
N/A
N/A
N/A
Current Ratio
1.14
N/A
N/A
N/A
Cash Ratio
0.42
N/A
N/A
N/A
Debt-to-Equity Ratio
0.30
N/A
N/A
N/A
Debt-to-Assets Ratio
0.17
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow